✦ LIBER ✦

Phase II study of liposomal doxorubicin and gemcitabine in the salvage treatment of ovarian cancer

✍ Scribed by D'Agostino, G; Ferrandina, G; Ludovisi, M; Testa, A; Lorusso, D; Gbaguidi, N; Breda, E; Mancuso, S; Scambia, G

Book ID: 109997768
Publisher: Nature Publishing Group
Year: 2003
Tongue: English
Weight: 87 KB
Volume: 89
Category: Article
ISSN: 0007-0920
DOI: 10.1038/sj.bjc.6601284

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II study of liposomal annamycin in

Phase II study of liposomal annamycin in the treatment of doxorubicin-resistant breast cancer

✍ Daniel J. Booser; Francisco J. Esteva; Edgardo Rivera; Vicente Valero; Laura Esp 📂 Article 📅 2002 🏛 Springer 🌐 English ⚖ 56 KB

Pegylated liposomal doxorubicin and gemc

Pegylated liposomal doxorubicin and gemcitabine in the front-line treatment of recurrent/metastatic breast cancer: a multicentre phase II study

✍ Adamo, V; Lorusso, V; Rossello, R; Adamo, B; Ferraro, G; Lorusso, D; Condemi, G; 📂 Article 📅 2008 🏛 Nature Publishing Group 🌐 English ⚖ 126 KB

Phase II study of the combination of peg

Phase II study of the combination of pegylated liposomal doxorubicin and topotecan in platinum-resistant ovarian cancer

✍ M. VERHAAR-LANGEREIS; A. KARAKUS; M. Van EIJKEREN; E. VOEST; E. WIT 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 76 KB

Phase I study of pegylated liposomal dox

Phase I study of pegylated liposomal doxorubicin and gemcitabine in patients with advanced malignancies

✍ Paula M. Fracasso; Kristie A. Blum; Benjamin R. Tan; Carole L. Fears; Nancy L. B 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 71 KB 👁 2 views

## Abstract ## BACKGROUND Pegylated liposomal doxorubicin (PEG‐LD) and gemcitabine have single‐agent activity in breast and ovarian carcinoma patients. We conducted a Phase I trial to evaluate the maximum tolerated dose (MTD) and toxicities of this combination in patients with advanced malignancie

A phase II study of pegylated liposomal

A phase II study of pegylated liposomal doxorubicin oxaliplatin and cyclophosphamide as second-line treatment in relapsed ovarian carcinoma

✍ M.R. VALERIO; P. TAGLIAFERRI; F. RASPAGLIESI; F. FULFARO; G. BADALAMENTI; C. ARC 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 106 KB

Pegylated liposomal doxorubicin in combi

Pegylated liposomal doxorubicin in combination with vinorelbine as salvage treatment in pretreated patients with advanced breast cancer: a multicentre phase II study

✍ Alexandros Ardavanis; Dimitris Mavroudis; Kostas Kalbakis; Nikolaos Malamos; Kos 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 292 KB